The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: a pathophysiological update
Administration is typically intravenous or intramuscular, which limits its accessibility compared to orally available or injectable peptides, but the clinical evidence supporting its use in serious neurological injury is stronger than that for almost any other peptide in this category
How often should you have a B12 booster
Similar content being viewed by others Introduction The concept of diabetes remission is driving a paradigm shift in our understanding of type 2 diabetes (T2D), no longer seen as an irreversible disease related to a progressive depletion of -cells and various chronic diabetes-related complications, but rather as a disease that can be reversible through a personalized approach (nutritional, pharmacological, or surgical) primarily aimed at weight loss or reduction of ectopic fat predominantly contained in the liver, pancreas, and muscle
Gastrointestinal Conditions BPC-157 was originally isolated from gastric juice, and its most robust preclinical evidence involves gastrointestinal healing